Silvercrest Asset Management’s Amicus Therapeutics FOLD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.55M | Buy |
968,231
+434,520
| +81% | +$2.49M | 0.04% | 417 |
|
|
2025
Q1 | $4.36M | Sell |
533,711
-1,544
| -0.3% | -$12.6K | 0.03% | 431 |
|
|
2024
Q4 | $5.04M | Sell |
535,255
-2,384
| -0.4% | -$22.5K | 0.03% | 422 |
|
|
2024
Q3 | $5.74M | Sell |
537,639
-3,099
| -0.6% | -$33.1K | 0.04% | 363 |
|
|
2024
Q2 | $5.36M | Buy |
540,738
+165,780
| +44% | +$1.64M | 0.04% | 388 |
|
|
2024
Q1 | $4.42M | Buy |
374,958
+16,033
| +4% | +$189K | 0.03% | 411 |
|
|
2023
Q4 | $5.09M | Sell |
358,925
-74
| -0% | -$1.05K | 0.04% | 370 |
|
|
2023
Q3 | $4.37M | Buy |
358,999
+78,615
| +28% | +$956K | 0.03% | 382 |
|
|
2023
Q2 | $3.52M | Buy |
280,384
+41,488
| +17% | +$521K | 0.03% | 418 |
|
|
2023
Q1 | $2.65M | Sell |
238,896
-189
| -0.1% | -$2.1K | 0.02% | 439 |
|
|
2022
Q4 | $2.92M | Sell |
239,085
-179,838
| -43% | -$2.2M | 0.02% | 419 |
|
|
2022
Q3 | $4.37M | Sell |
418,923
-10,707
| -2% | -$112K | 0.04% | 349 |
|
|
2022
Q2 | $4.61M | Sell |
429,630
-21,728
| -5% | -$233K | 0.04% | 357 |
|
|
2022
Q1 | $4.27M | Buy |
451,358
+4,899
| +1% | +$46.4K | 0.03% | 398 |
|
|
2021
Q4 | $5.16M | Buy |
446,459
+1,566
| +0.4% | +$18.1K | 0.03% | 370 |
|
|
2021
Q3 | $4.25M | Sell |
444,893
-8,262
| -2% | -$78.9K | 0.03% | 404 |
|
|
2021
Q2 | $4.37M | Buy |
453,155
+147,980
| +48% | +$1.43M | 0.03% | 412 |
|
|
2021
Q1 | $3.02M | Buy |
305,175
+131,253
| +75% | +$1.3M | 0.02% | 442 |
|
|
2020
Q4 | $4.02M | Sell |
173,922
-27,754
| -14% | -$641K | 0.03% | 389 |
|
|
2020
Q3 | $2.85M | Sell |
201,676
-3,619
| -2% | -$51.1K | 0.02% | 416 |
|
|
2020
Q2 | $3.1M | Buy |
+205,295
| New | +$3.1M | 0.03% | 400 |
|